European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.47% to 1,438.05 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by internet ad company Criteo (CRTO) and biotech firm Evaxion Biotech (EVAX), which rose 2.7% and 2.4%, respectively. They were followed by telecommunications company Ericsson (ERIC) and pharmaceutical company Novo Nordisk (NVO), which were up 0.4% and 0.2%, respectively.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and financial services company Banco Santander (SAN), which fell 4.2% and 3.8%, respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and accommodations booking site trivago (TRVG), which dropped 3.2% and 3%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana (NCNA) and TC Biopharm (TCBP), which advanced 5.9% and 4.9%, respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Trinity Biotech (TRIB), which increased 3% and 2.7%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Biodexa Pharmaceuticals (BDRX), which tumbled 23% and 12%, respectively. They were followed by education company Pearson (PSO) and financial services company HSBC (HSBC), which were down 5% and 2.5%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。